Sort by

Send to

Choose Destination

Links from PubMed

Items: 14


Psychiatric comorbidity and medication use in adults with autism spectrum disorder.

Buck TR, Viskochil J, Farley M, Coon H, McMahon WM, Morgan J, Bilder DA.

J Autism Dev Disord. 2014 Dec;44(12):3063-71. doi: 10.1007/s10803-014-2170-2.


Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.

Mouti A, Reddihough D, Marraffa C, Hazell P, Wray J, Lee K, Kohn M.

Trials. 2014 Jun 16;15:230. doi: 10.1186/1745-6215-15-230.


Treatment of comorbid anxiety and autism spectrum disorders.

Nadeau J, Sulkowski ML, Ung D, Wood JJ, Lewin AB, Murphy TK, May JE, Storch EA.

Neuropsychiatry (London). 2011 Dec;1(6):567-578.


Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression.

Charlot L, Deutsch CK, Albert A, Hunt A, Connor DF, McIlvane WJ Jr.

J Ment Health Res Intellect Disabil. 2008;1(4):238-253.


Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs.

Lopata C, Toomey JA, Fox JD, Thomeer ML, Volker MA, Lee GK.

Autism Res Treat. 2013;2013:384527. doi: 10.1155/2013/384527.


Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.

Davis NO, Kollins SH.

Neurotherapeutics. 2012 Jul;9(3):518-30. doi: 10.1007/s13311-012-0126-9. Review.


High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.

Logan SL, Nicholas JS, Carpenter LA, King LB, Garrett-Mayer E, Charles JM.

Ann Epidemiol. 2012 Jan;22(1):1-8. doi: 10.1016/j.annepidem.2011.10.007.


Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities.

Charlot L, Abend S, Ravin P, Mastis K, Hunt A, Deutsch C.

J Intellect Disabil Res. 2011 Feb;55(2):199-209. doi: 10.1111/j.1365-2788.2010.01294.x.


Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice.

Frye CA, Llaneza DC.

Physiol Behav. 2010 Jun 1;100(3):264-7. doi: 10.1016/j.physbeh.2010.03.005.


A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG.

J Autism Dev Disord. 2009 Sep;39(9):1339-49. doi: 10.1007/s10803-009-0750-3.


Stimulant medication treatment of target behaviors in children with autism: a population-based study.

Nickels K, Katusic SK, Colligan RC, Weaver AL, Voigt RG, Barbaresi WJ.

J Dev Behav Pediatr. 2008 Apr;29(2):75-81.


Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.

Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE.

Pediatrics. 2008 Mar;121(3):e441-8. doi: 10.1542/peds.2007-0984.


Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

Aman MG, Vinks AA, Remmerie B, Mannaert E, Ramadan Y, Masty J, Lindsay RL, Malone K.

Clin Ther. 2007 Jul;29(7):1476-86.

Items per page

Supplemental Content

Support Center